lyra health investors

"I've known David for over 10 years, and his focus on one of the world's most important topics, addressing and solving mental health care, is truly inspiring," said Marc Stad, Founder and Managing Partner at Dragoneer. This new funding will help Lyra deliver comprehensive and culturally responsive mental health care for organizations and their employees and families, said Ebersman. Delivering mental health care for diverse employee populations around the world is one of the most pressing and complex issues for employers today, and this new funding will help Lyra accelerate our plans to deliver comprehensive, global solutions.. Dragoneer led the round and was joined by new investor Salesforce Ventures along with existing investor Coatue. Modern Health operates as a mental health benefits platform for employers. With the new funding, Lyra will accelerate its delivery of comprehensive, evidence-based, culturally responsive mental health care benefits for employees and their families around the world. Jan 28, 2021, 08:00 ET. More than 83% of U.S. employees are experiencing mental health issues, according to research Lyra Health conducted in 2020 in partnership with the National Alliance of Healthcare Purchaser Coalitions. Lyra's co-founder and CEO, David Ebersman, left his job as Meta's chief financial officer in 2014 to tackle the problem by making it easier to find and get treatment and . Upon commercialization on a region-by-region basis, Lyra also will be entitled to receive low double-digit royalties based on net sales of LYR-210 in the licensed territories. Constrained optimization for provider groups, Personalized adaptive risk assessment service, Co-Founder, Chief Executive Officer & Board Member, To view Lyras complete valuation and funding history, request access, To view Lyras complete cap table history, request access, Youre viewing 2 of 29 competitors. Coatue Management invested in Lyra Health's Series G funding round. Lyra provides evidence-based care that supports people across all facets of mental health, from wellness and preventive care to the most severe conditions. our sites and services. Get the full list, To view Lyras complete patent history, request access, Youre viewing 5 of 16 executive team members. For more information about Lyra Healths innovative mental health benefits for employers, visit lyrahealth.com. With Lyra, benefits leaders can offer employees fast, reliable access to providers who practice evidence-based mental health care treatments. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. Lyra Therapeutics: Investor Contact: Argot Partners 212-600-1902 Lyra@argopartners.com Media Contact: Kathryn Morris 914-204-6412 kathryn@theyatesnetwork.com LianBio Investor Contact: Elizabeth . The company's platform connects members to a curated network of therapists and coaches through live video therapy, coaching and digital self-care tools, resulting in faster access to care and better outcomes than traditional plans . This new funding will help Lyra deliver comprehensive and culturally responsive mental health care for organizations and their employees and families," said Ebersman. Their latest acquisition was ICAS World on January 19, 2022. About Lyra HealthLyra Health is the leading provider of Workforce Mental Health benefits, serving 10 million global employees and their dependents. from 8 AM - 9 PM ET. The company was founded in 2017 and is based in San Francisco, California. Get the full list, Youre viewing 5 of 10 board members. (Neither company can help people who are in a life-threatening mental health crisis and instead link to resources like the National Suicide Prevention Line.) Lyra Health's announcement confirms an earlier report by The Information. Coatue led the round and was joined by new investor Sands Capital, along with existing investors. Lyra's curated network includes more than 5,000 coaches, therapists, and doctors in the U.S., with an additional 85,000 providers available worldwide through global partnerships. Join us for Breakthrough, Lyras annual mental health conference, in San Francisco. That speaks to how hard access has been for most people for most of their life.. The platform offers scientifically-backed tools and training for healthier, happier, more human organizations. The highwater mark was set pre-pandemic when the telepsychiatry and specialty pharmacy company Genoa Health sold to UnitedHealth Group for $2.5 billion in 2018. This is the only company I've ever worked with, where we don't have to do marketing, says Kocher. Jessi Gold, a psychiatrist and assistant professor at Washington University in St. Louis, has been conducting virtual appointments but prefers to see patients in person. While Lyra has grown steadily since its founding in 2015, 2020 was quite the breakout year for Lyra, which more than doubled its customer base to over 2 million members and raised about $185 million across two different funding rounds.That funding helped push Lyra's total valuation above $1 billion, making it one of a very few unicorns in the behavioral health spaces. Before the pandemic, it was already estimated that less than half of adults and children living with mental health conditions in the U.S. went without any treatment. Bob Kocher, a partner at Venrock, is betting on Lyra Health, the company he co-founded in 2015 alongside former Facebook CFO David Ebersman, to take off. Transforming Access to Mental Health Care Around the WorldNearly 1 billion people worldwide suffer from a mental health disorder, yet more than 70% of people don't have access to the care they need. Unmind operates as a workplace mental health platform. Lyras approach to mental health care has been proven to help members improve or recover faster and reduce medical claims costs for employers.For more information, visit lyrahealth.com and follow us on LinkedIn, Facebook, and Twitter. Date Investors Percent Raised Target Size; January 28, 2021: 33: 100%: "Lyra is dedicated to redefining access to high-quality mental healthcare for both individuals and employers on a global scale," said Sisco. 508 904 9446 Lyra Health peak revenue was $9.3M in 2022. Existing partners also participated in the funding round. Lyra Health Investors. Dragoneer has a history of partnering with management teams growing exceptional companies characterized by sustainable differentiation and superior economic models. January 19, 2022 08:00 AM EDT, BURLINGAME, Calif. Lyra Health, the leading provider of innovative Workforce Mental Health solutions for employers, today announced it has completed a $235M financing.Dragoneer led the round and was joined by new investor Salesforce Ventures along with existing investor Coatue. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Lyra Health's annual revenues are $100-$500 million, 5416 Management, Scientific & Technical Consulting Services. Lyra Health, a provider of mental health benefits for employees, has raised $200 million in the latest funding round, bringing its total valuation to $4.6 billion. Argot Partners Media Contact: and our Code of Business Conduct and Ethics in the "Governance" section of the "Investors & News" page of our website located at www . As part of the agreement, LianBio will also have the first right to obtain development and commercial rights in the licensed territories to Lyras LYR-220, an anti-inflammatory, intra-nasal, drug matrix in development for the treatment of CRS patients who have undergone a prior sinus surgery but continue to have persistent disease. The digital behavioral-health-benefits platform Lyra Health announced today the closing of its Series E funding round worth $187 million. BURLINGAME, Calif., June 14, 2021 /PRNewswire/ -- Lyra Health, the leading provider of comprehensive mental health care benefits for employers, today announced . 2023 State of Workforce Mental Health Report, Why Culturally Responsive Care Must Be Part of Your Mental Health Benefits Strategy, Diversity, Equity, Inclusion, and Belonging, Limit the Use of My Sensitive Personal Information. BURLINGAME, Calif, Jan. 28, 2021 /PRNewswire/ --Lyra Health, the leading provider of comprehensive mental health care benefits for employers, today announced a Series E financing round of $187 million. June 14, 2021 08:00 AM ET, BURLINGAME, Calif. Lyra Health, the leading provider of comprehensive mental health care benefits for employers, today announced it has completed a $200M financing. When the pandemic hit, there was a two-week pause, says Lisa Suennen, a longtime healthcare investor who leads the venture fund at the law firm and consultancy Manatt, Phelps & Phillips. Dragoneer has been an investor in companies such as Airbnb, Alibaba, Atlassian, AppFolio, Bytedance, Carbon Health, Ceridian, Chime, Datadog, Doordash, Duck Creek, Livongo, Maven, PointClickCare, Procore, Slack, Samsara, ServiceTitan, Snowflake, Spotify, Uber, UiPath, and others. The companys current pipeline of therapeutics target tissues deep in the ear, nose and throat passages and are designed to deliver continuous drug therapy for months following a single non-invasive, in-office administration. Kathryn Morris Apr 18, 2022. San Francisco-based 6sense closed a $200 million Series E co-led by new investors Blue Owl and MSD Partners at a $5.2 billion valuation . The latest fundraising was led by investor hedge fund Coatue Management, with participation from new investor Sands Capital. Theres also concern that the hyper focus on technology and virtual care is like putting lipstick on a pig. Log In. . Many mental health providers choose to operate out of insurance networks, since the reimbursement rates are so low. "The traditional mental health care system cannot address the critical needs people have today. Number of Investors 4. Lyra also today announced the addition of Robynne Sisco to its Board of Directors. Through the partnership, Lyra is making it easier for employers to offer a wide range of mental health tools from a single platform. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Legal Name Lyra Health, Inc. Hub Tags Unicorn. Twill provides digital therapeutics and care delivery models focused on mental and physical health. By year-end, venture investors poured a record-setting $1.5 billion into mental health-related startups. Leading self-insured employers partner with Lyra to tailor value-driven mental health benefits programs specific to their workforce. Investor Contact: Lyra Health acquired 1 company. Get the full list, To view Lyras complete acquisitions history, request access, To view Lyras complete subsidiaries history, request access, Morningstar Institutional Equity Research. But it was the Covid-19 pandemic and collective psychological fallout that finally mainstreamed mental health. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Developer of a digital health platform designed to transform mental health care through technology along with the human touch. Lyra Health's valuation in June 2021 was $4,600M. Top investors are Durable Capital Partners, Fidelity Management & Research, and Baillie Gifford. Several VC-backed companies also employ mental health coaches. These people cant diagnose or treat clinical conditions but are supposed to help users who are dealing with stressors in their jobs or relationships before they spiral. Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. and other contracted partners to be your Lyra Care Navigator Team and deliver clinical services. For more information, visit lyrahealth.com and follow us on LinkedIn, Facebook, and Twitter. The only thing that is under-treated in American healthcare is mental health care, says Kocher, adding that historically mental health businesses havent been profitable. Lyra helps companies improve access to effective, high-quality mental health care for their employees. Contact:Kaitlin Rebella[emailprotected] (248) 318-4303, Cision Distribution 888-776-0942 Resources. I'm a senior writer covering healthcare technology. With Lyra, benefits leaders can offer employees fast, reliable access to providers who practice evidence-based mental health care treatments. Lyra hit unicorn status in 2020 in a pandemic-fueled funding round, and Modern Health, BetterUp and Ginger joined the club in 2021. Lyras innovative Blended Care Therapy pairs video counseling sessions, one-to-one messaging, and digital activities prescribed by the provider to support individuals in their everyday lives. Personalize which data points you want to see and create visualizations instantly. . "Providing high-quality mental health care for diverse employee populations around the world is one of the most critical and challenging issues for employers today. CBI websites generally use certain cookies to enable better interactions with. elizabeth.anderson@lianbio.com These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the companys actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the fact that the company has incurred significant losses since inception and expects to incur losses for the foreseeable future; the companys need for additional funding, which may not be available; the companys limited operating history; the fact that the company has no approved products; the fact that the companys product candidates are in various stages of development; the fact that the company may not be successful in its efforts to identify and successfully commercialize its product candidates; the fact that clinical trials required for the companys product candidates are expensive and time-consuming, and their outcome is uncertain; the fact that the FDA may not conclude that certain of the companys product candidates satisfy the requirements for the Section 505(b)(2) regulatory approval pathway; the companys inability to obtain required regulatory approvals; effects of recently enacted and future legislation; the possibility of system failures or security breaches; effects of significant competition; the fact that the successful commercialization of the companys product candidates will depend in part on the extent to which governmental authorities and health insurers establish coverage, adequate reimbursement levels and pricing policies; failure to achieve market acceptance; product liability lawsuits; the fact that the company relies on third parties for the manufacture of materials for its research programs, pre-clinical studies and clinical trials; the companys reliance on third parties to conduct its preclinical studies and clinical trials; the companys inability to succeed in establishing and maintaining collaborative relationships; the companys reliance on certain suppliers critical to its production; failure to obtain and maintain or adequately protect the companys intellectual property rights; failure to retain key personnel or to recruit qualified personnel; difficulties in managing the companys growth; effects of natural disasters; the fact that the global pandemic caused by COVID-19 could adversely impact the companys business and operations, including the companys clinical trials; the fact that the price of the companys common stock may be volatile and fluctuate substantially; significant costs and required management time as a result of operating as a public company and any securities class action litigation. With an estimated 88 million adult CRS patients in China alone, we believe LYR-210 has the potential to address a significant unmet medical need and meaningfully improve the standard of care for patients in Asia.. When typing in this field, a list of search results will appear and be automatically updated as you type. You can read more about your cookie choices at our privacy policyhere. Mental health issues are much more pervasive than is commonly known, and Lyra is thoughtfully redefining access to care by providing broad-based solutions through employers. LifeStance Health Group, an outpatient mental health provider backed by investment firm TPG Capital, announced plans this month to go public at an estimated more than $6 billion valuation. Despite federal laws requiring mental health to be reimbursed at the same rates as physical illness, many people with insurance still face hurdles, from long wait times to denial of claims battles. Competitors of Lyra Health include Spring Health, Twill, Strove, Valera Health, Alma, Brightline, Sanarai, TaskHuman, moka.care, Panda and 21 more. Investor Contact: Lyra Health has raised around $910 million in funding over 8 rounds from investors like Salesforce Ventures, Coatue, and Emerson Collective. While the company may elect to update such forward-looking statements at some point in the future, it disclaims any obligation to do so, even if subsequent events cause its views to change. Lyra Health's revenue is $9.3 Million - Learn more about Lyra Health's revenue by exploring their annual revenue, historical revenue, quarterly revenue, and revenue per employee. January 21, 2022. Some, like San Francisco, Calif.-based Calm, valued at $2 billion, dont have a medical component. Lyra's approach to mental health care has been proven to help members improve or recover faster and reduce medical claims costs for employers. This latest financing round will allow Lyra to continue to develop new and innovative care solutions while reaching new customers and members.". Lyra's matching technology and innovative digital platform connect members to a curated network of top . Seed: Venrock: Seed: Providence Health & Services: Series A: Origin Capital Management . The introduction of our novel, integrated ENT drug and delivery solution to the large patient populations in Asian markets supports our planned global commercialization strategy., CRS patients who have failed medical management are currently left with limited and invasive options to manage their disease, said Yizhe Wang, Ph.D., Chief Executive Officer of LianBio. Lyra Therapeutics, Inc. is a clinical-stage therapeutics company leveraging its proprietary XTreo platform to enable precise, sustained, local delivery of medications to diseased tissues not accessible with conventional therapeutic approaches. Any such forward-looking statements represent managements estimates as of the date of this press release. Lyra Health has 22 investors. With Lyra, benefits leaders can offer employees fast, reliable access to providers who practice evidence-based mental health care treatments. Burlingame, California-based Lyra, valued at $2.3 billion in a January funding round, is specifically targeting large employers with customers including Morgan Stanley, eBay and Genentech. Lyra Health doubles customers, expands to serve more than 2 million members. Note: Lyra Health's revenues are gauged from an analysis of company filings. Industry: Health Care Services & Hospitals. Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China. "2020 put the need for mental health care transformation in sharp focus, as more people sought help during these extraordinary and difficult times," said David Ebersman, Lyra Health CEO and co-founder. Learn more. One in five people struggle with mental health challenges such as anxiety, depression, or substance use disorder, said David Ebersman, Lyra Health CEO and co-founder. tyler.gagnon@canalecomm.com, million adult CRS patients in China alone, we believe LYR-210 has the potential to address a significant unmet medical need and meaningfully improve the standard of care for patients in Asia., Internet Explorer presents a security risk. The company, which now has an enterprise division that sells to businesses, claims to help users reduce stress and sleep better. You can access direct insights and strategies from . site you are consenting to these choices. In 2020, peer-reviewed Lyra research demonstrated the effectiveness of the Blended Care treatment program for clients with depression and anxiety. Lyra Health now worth $2.3B on heels of . Lyra delivers mental health for employees and family members at leading multinational companies, including eBay; Genentech, a member of the Roche Group; Uber; and VCA Animal Hospitals. I understand from both a business perspective and a needs perspective why [startups] are interested in mental health right now, she says, but the potential to really prey on that need, or worse, the patients, terrifies me..

Home Theater Candy Display, Outer Banks Filming Locations, Articles L

lyra health investors

lyra health investors